1. Home
  2. PFBC vs AVLN Comparison

PFBC vs AVLN Comparison

Compare PFBC & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preferred Bank

PFBC

Preferred Bank

HOLD

Current Price

$105.41

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$34.28

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PFBC
AVLN
Founded
1991
N/A
Country
United States
United States
Employees
324
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
PFBC
AVLN
Price
$105.41
$34.28
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$102.67
N/A
AVG Volume (30 Days)
67.8K
155.1K
Earning Date
04-22-2026
N/A
Dividend Yield
3.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.94
N/A
Revenue Next Year
$8.31
N/A
P/E Ratio
$8.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.50
$24.90
52 Week High
$112.26
$40.17

Technical Indicators

Market Signals
Indicator
PFBC
AVLN
Relative Strength Index (RSI) 54.09 49.11
Support Level $103.06 $34.22
Resistance Level $105.95 $39.62
Average True Range (ATR) 2.00 1.95
MACD 0.09 -0.48
Stochastic Oscillator 83.03 27.69

Price Performance

Historical Comparison
PFBC
AVLN

About PFBC Preferred Bank

Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking, which include Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: